Cargando…

Soluble PD-L1 in Serum and Urine in Urinary Bladder Cancer Patients

SIMPLE SUMMARY: Non-invasive diagnostic and prognostic biomarkers for urinary bladder cancer (BC) are eagerly awaited, since these could improve patient’s quality of life and reduce resources and costs for the health care system. The PD-1/PD-L1 axis is an important immune escape mechanism for tumors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vikerfors, Anders, Davidsson, Sabina, Frey, Janusz, Jerlström, Tomas, Carlsson, Jessica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616046/ https://www.ncbi.nlm.nih.gov/pubmed/34830993 http://dx.doi.org/10.3390/cancers13225841

Ejemplares similares

Soluble Levels of CD163, PD-L1, and IL-10 in Renal Cell Carcinoma Patients
por: Davidsson, Sabina, et al.
Publicado: (2022)

Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
por: Tosev, Georgi, et al.
Publicado: (2021)

Oxidative Stress Markers in Urine and Serum of Patients with Bladder Cancer
por: Galiniak, Sabina, et al.
Publicado: (2023)

The influence of prostatic Cutibacterium acnes infection on serum levels of IL6 and CXCL8 in prostate cancer patients
por: Ugge, Henrik, et al.
Publicado: (2018)

Publisher Correction: Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
por: Tosev, Georgi, et al.
Publicado: (2021)

Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction
por: Okuyama, Mai, et al.
Publicado: (2019)

Urine and Serum Exosomes as Novel Biomarkers in Detection of Bladder Cancer
por: Elsharkawi, Fathia, et al.
Publicado: (2019)

Isolated Fungal Balls in Urinary Bladder Presenting as Acute Retention of Urine
por: Hameed, Tariq, et al.
Publicado: (2020)

Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer
por: Zhu, Xinxin, et al.
Publicado: (2017)

Soluble sPD-L1 and Serum Amyloid A1 as Potential Biomarkers for Lung Cancer
por: Jovanović, Dragana, et al.
Publicado: (2019)

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
por: Niu, Mengke, et al.
Publicado: (2022)

Urinary soluble (pro)renin receptor excretion is associated with urine pH in humans
por: Sasaki, Nobukazu, et al.
Publicado: (2021)

Cutibacterium acnes Induces the Expression of Immunosuppressive Genes in Macrophages and is Associated with an Increase of Regulatory T-Cells in Prostate Cancer
por: Davidsson, Sabina, et al.
Publicado: (2021)

Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder Cancer
por: Reinert, Thomas
Publicado: (2012)

Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0
por: Häggström, Christel, et al.
Publicado: (2022)

Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
por: Imai, Yushi, et al.
Publicado: (2020)

Cumulative incidence of midline incisional hernia and its surgical treatment after radical cystectomy and urinary diversion for bladder cancer: A nation-wide population-based study
por: Liedberg, Fredrik, et al.
Publicado: (2021)

Expression and prognostic value of PD-L1 in non-schistosoma-associated urinary bladder squamous cell carcinoma
por: Liu, Zhenhua, et al.
Publicado: (2020)

Acne in late adolescence and risk of prostate cancer
por: Ugge, Henrik, et al.
Publicado: (2017)

Currently Used Laboratory Methodologies for Assays Detecting PD-1, PD-L1, PD-L2 and Soluble PD-L1 in Patients with Metastatic Breast Cancer
por: Jeong, Seri, et al.
Publicado: (2021)

The potential role of miR-126, miR-21 and miR-10b as prognostic biomarkers in renal cell carcinoma
por: Carlsson, Jessica, et al.
Publicado: (2019)

Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder
por: McNeil, Brian K, et al.
Publicado: (2014)

Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood
por: Krueger, Kimberly, et al.
Publicado: (2022)

The Activity of the Enzymes Sulphatase and β-Glucuronidase in the Urine, Serum and Bladder Tissue
por: Boyland, E., et al.
Publicado: (1955)

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer
por: de Jong, Florus C., et al.
Publicado: (2021)

Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer
por: Holmberg, Lars, et al.
Publicado: (2022)

M2 macrophages and regulatory T cells in lethal prostate cancer
por: Erlandsson, Ann, et al.
Publicado: (2018)

PD-L1 Expression in Muscle-Invasive Urinary Bladder Urothelial Carcinoma According to Basal/Squamous-Like Phenotype
por: Kim, Bohyun, et al.
Publicado: (2020)

High Quality Performance of Novel Immunoassays for the Sensitive Quantification of Soluble PD-1, PD-L1 and PD-L2 in Blood
por: Krueger, Kimberly, et al.
Publicado: (2022)

The effect of hypoxia on PD-L1 expression in bladder cancer
por: Smith, Vicky, et al.
Publicado: (2021)

Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer
por: Protheroe, A S, et al.
Publicado: (1999)

Correlation and Significance of Urinary Soluble Fas and Vascular Endothelial Growth Factor in Bladder Urothelial Cancer
por: Yang, Huixiang, et al.
Publicado: (2015)

Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
por: Bryan, R T, et al.
Publicado: (2015)

The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma
por: Chang, Boyang, et al.
Publicado: (2018)

Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?
por: Bier, Simone, et al.
Publicado: (2018)

Proteomes of Uropathogenic Escherichia coli Growing in Human Urine and in J82 Urinary Bladder Cells
por: Andersen, Sisse, et al.
Publicado: (2022)

Is the Urinary and Gut Microbiome Associated With Bladder Cancer?
por: Chorbińska, Joanna, et al.
Publicado: (2023)

Study of the clinicopathological features of soluble PD-L1 in lung cancer patients
por: Sasaki, Takanobu, et al.
Publicado: (2023)

Epigenetic Markers for Bladder Cancer in Urine
por: Kim, Wun-Jae, et al.
Publicado: (2007)

Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment
por: Martín-Vírgala, Julia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f1anngqog0iu1ftja74rtl701i